• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Healthomicron

You will probably get Omicron. It’s time to adjust expectations about what beating COVID means

Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
Sophie Mellor
By
Sophie Mellor
Sophie Mellor
Down Arrow Button Icon
January 12, 2022, 12:45 PM ET

Omicron is currently surging through the U.S., infecting huge numbers of people and causing record-high hospitalization rates. 

Its high transmissibility means that even people who are vaccinated and wear masks in public places are contracting the variant. But now the U.S. is better equipped to deal with COVID than it was when the first wave hit in early 2020. Vaccines have left many people at least partially protected against coming down with a severe case. New antiviral drugs are on the horizon, and the government has committed to sending millions of tests to homes and schools.  

Now, two years after COVID first reached U.S. shores, a new variant that evades current vaccines, and the prospect of more to come in the future, some public health experts believe that it’s time to change the way we think about COVID, moving away from the idea that we will vanquish the virus completely and instead learn to live with it as an endemic disease like the flu. 

“For a lot of people there has been this hope that there will be a day where victory will be declared. They will say, ‘Today was the end of COVID, and tomorrow we will live in a COVID-free world again,’” says Dr. Wafaa El-Sadr, professor of epidemiology and medicine at Columbia University. “I think that is really unrealistic, and not feasible.”

You will probably get Omicron

Early studies have shown that Omicron’s R rate, or the average number of secondary infections an infected person will produce, is around 3.7, according to the U.K.’s Health Security Agency. This is around 2.7 to 3.7 times higher than the Delta variant, according to a preprint study conducted by the University of Copenhagen, Statistics Denmark, and Statens Serum Institut (SSI), which cites Omicron’s ability to circumvent vaccines as the key to how easily it spreads​​.

In practice, this means that even people who got two vaccines, a booster shot, and take other precautions are still contracting the virus. 

U.S chief medical officer Dr. Anthony Fauci said on Tuesday that the likelihood of anyone escaping Omicron is slim. 

“Omicron, with its extraordinary, unprecedented degree of efficiency of transmissibility, will ultimately find just about everybody,” said Fauci.  

That same day, the World Health Organization predicted that by mid-March, at least half of the population of Europe will be infected with COVID. 

The fact that Omicron is able to evade vaccines has already gone a long way to reduce any potential shame around contracting COVID, according to Amitabh Chandra, a professor of health policy at the Harvard Kennedy School.

The sky-high transmission rate is eroding the division between the idea of reckless people who get COVID because they took no precautions, and others who have been cautious but have still come down with a case. 

“If a lot of people are getting COVID despite being very careful, then I think the stigma of getting COVID-19 will fall substantially,” Chandra said. “The politics of the disease has changed.”

But we have more tools to reduce infection severity

When it seems like catching the Omicron variant is inevitable, the question is no longer how to avoid it, but rather mitigating how bad it will be when it finally comes. 

Although studies have shown that Omicron infects vaccinated people, those people are more likely to experience less severe illness. And along with vaccines, new antiviral pills that can be used to treat people after they contract COVID are slowly hitting the U.S. market.

Around 63% of the U.S. population is fully vaccinated and around 90% of the country’s vulnerable and elderly people are fully vaccinated. A substantial portion of the population has also already lived through COVID-19, giving them at least some immune response against the disease. 

To Chandra, that means that the cost of a restrictive measure like lockdown, particularly for low-income people, to try to prevent the spread of the disease outweighs the number of lives it will save, and that we should rethink how to combat the disease.

“When the vaccination for the elderly is 90% and the death rate is much smaller and the potential for economic carnage of the poor is enormous, we’ve got to change our answer,” Chandra told Fortune.

Why it’s still important to still take precautions right now

Although Omicron appears to be less severe among vaccinated people, the high transmissibility rates mean that it’s spreading more rapidly than any other variant. And when more people get sick, even a lower percentage of severe cases leads to overwhelmed hospitals.

Around 600 U.S. counties are currently at full capacity with no hospital beds available, according to the COVID-19 Hospital Capacity Circuit Breaker Dashboard, a tool created by Dr. Jeremy Faust that collects real-time data of hospital occupancy, and another 476 counties are expected to reach capacity within the next seven days. 

Many hospitals are also struggling with a critical shortage of nurses, doctors, and other medical staff who have either quit or have been infected with COVID and are isolating. 

Additionally, the supply of antiviral drugs that many hoped would quell the rush of Omicron across the country has been severely limited by manufacturing delays and supply-chain issues, rendering them largely ineffective at the moment.  

To make sure people don’t contribute to burdening overtaxed health care systems, governments around the world are still advising people to have limited social gatherings and work from home if possible.

So what does the future look like? 

Both El-Sadr and Chandra agree that with the prevalence of vaccines, boosters, and the hopeful arrival of new antiviral pills, the time for lockdowns is over.

Advocating a lockdown in January 2022 “in the presence of all of this scientific advancement and in the presence of a virus that is substantially less virulent than the earlier strains, seems irresponsible to me,” says Chandra. 

The argument over how to proceed during the next few months is happening in Europe, where they are considering treating COVID as an endemic illness and moving beyond pandemic-style restrictions after Spain’s prime minister, Pedro Sánchez, called on the European Union this week to debate the possibility of treating COVID-19 like the flu. Switzerland joined the fight today, suggesting COVID may be shifting to an endemic phase. 

Former Microsoft CEO Bill Gates said in Twitter Q&A on Tuesday that after the Omicron surge, there will be fewer cases, and COVID could be “treated more like seasonal flu.” 

Chandra emphasizes, however, that taking a pragmatic approach to Omicron, considering how easily it spreads, is not akin to giving up, and adds that more vaccines, more vaccine mandates, and better availability of antigen testing is the way forward.

“I agree with people who say we don’t want to give up,” he says. “But that doesn’t mean the only way to not give up is to have a lockdown.”

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.
About the Author
Sophie Mellor
By Sophie Mellor
LinkedIn iconTwitter icon
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

hoskins
Commentaryoffices
Gensler Co-Chair: Hot-desking was supposed to save money. It may be costing you your culture
By Diane HoskinsApril 30, 2026
5 hours ago
raw milk
Politicsmilk
Risk of paralysis, bacteria, even death is no match for Americans’ thirst for raw milk
By Laura Ungar, Jonel Aleccia and The Associated PressApril 29, 2026
20 hours ago
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
HealthDietary Supplements
The Best Protein Shakes of 2026: Tasted and Approved by Nutrition Experts
By Christina SnyderApril 29, 2026
1 day ago
aging
HealthLongevity
We’re the CEOs of Peloton and the Hospital for Special Surgery. Living longer isn’t enough, we need to live better, too
By Bryan T. Kelly and Peter SternApril 29, 2026
1 day ago
Bruce Broussard, HP CEO
AIProductivity
AI is changing who gets to be an expert. Are your colleagues ready to become ‘directors of intelligence’?
By Bruce BroussardApril 29, 2026
1 day ago
Robert F. Kennedy Jr. sits at a cafeteria table with schoolchildren.
EconomyEducation
More than two-thirds of U.S. schools say they’re unable to afford the cost of student free lunch—and MAHA’s dietary guidelines may make it worse
By Sasha RogelbergApril 29, 2026
1 day ago

Most Popular

Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
Success
Apple cofounder Ronald Wayne—whose stake would be worth up to $400 billion had he not sold it in 1976—says that at 91, he has no regrets
By Preston ForeApril 27, 2026
3 days ago
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’
Economy
Jamie Dimon gets candid about national debt: ‘There will be a bond crisis, and then we’ll have to deal with it’
By Eleanor PringleApril 29, 2026
1 day ago
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointee
Banking
‘They left me no choice’: Powell isn’t going anywhere—blocking Trump from another Fed appointee
By Eva RoytburgApril 29, 2026
21 hours ago
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workers
AI
‘The cost of compute is far beyond the costs of the employees’: Nvidia executive says right now AI is more expensive than paying human workers
By Sasha RogelbergApril 28, 2026
2 days ago
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
Big Tech
Google Cloud revenue is now 18% of Alphabet's business. Is this the beginning of the end of Google's search identity?
By Alexei OreskovicApril 29, 2026
14 hours ago
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPEC
Energy
‘Take the money and run’: Johns Hopkins economist Steve Hanke on why the UAE quit OPEC
By Shawn TullyApril 29, 2026
1 day ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.